Exhibiting a y-o-y growth of 4.5%, global sales of parenteral packaging products are estimated to be valued at USD 12,791.2 million in 2024. Over the forecast period, demand for parenteral packaging is projected to rise at a CAGR of 4.6%. By 2034, the global parenteral packaging market size is set to reach USD 20,115.6 million.
Prefilled syringes are expected to account for a value share of about 39.6% by the end of 2034. This is attributable to the rising popularity of prefilled syringes owing to their better convenience and ease of use.
The plastic segment dominates the global parenteral packaging industry, and the trend is expected to continue through 2034. It is poised to witness a CAGR of 4.6% during the forecast period, holding a prominent share of around 56.1%.
Key Factors Boosting Growth of Parenteral Packaging Market
Key Parenteral Packaging Market Trends
| Attributes | Key Insights |
|---|---|
| Base Value (2023) | USD 12,235.4 million |
| Estimated Parenteral Packaging Market Value (2024) | USD 12,791.2 million |
| Projected Parenteral Packaging Market Revenue (2034) | USD 20,115.6 million |
| Value CAGR (2024 to 2034) | 4.6% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global market of parenteral packaging recorded a CAGR of 3.8% during the historical period. Total market valuation at the end of 2023 reached about USD 12,235.4 million. In the forecast period, parenteral packaging demand is poised to increase at a 4.6% CAGR.
The parenteral packaging market is anticipated to witness a positive growth trajectory. With glass and plastic offering various advantages in the healthcare industry, there is a rising demand for a primary protective system.
The sale of primary packaging for parenteral products is on the rise. Parenteral packaging has a significant role in the pharmaceutical industry as it offers great stability and safety to stored medical formulations.
Parenteral packaging is intended to protect the product from the external environment and keep the drug intact till it is administered. It is used for sterile medications that are administered by infusion or injection. The growing need for protecting sensitive drugs from environmental factors is expected to fuel demand for parenteral packaging.
Rising focus on enhancing patient safety and convenience is triggering innovation in parenteral drug packaging. Prefilled syringes, ready-to-mix systems, and vials with tamper-evident closures are gaining immense traction. This is due to their ability to minimize medication errors and improve ease of administration.
There has been significant growth in spending on sterile parenteral contract services. This, in turn, is expected to create growth opportunities for parenteral packaging manufacturers during the assessment period.
The prevalence of diabetes and other chronic diseases is rising sharply. According to the World Health Organization (WHO), around 783 people will be living with diabetes in 2045. This will create high demand for insulin as well as parenteral packaging solutions
Ongoing advancements in drug delivery technologies, such as pre-filled syringes, vials, and cartridges, contribute to the growth of the parenteral packaging market. These technologies enhance patient convenience, reduce the risk of contamination, and improve overall drug stability.
There is an increasing demand for healthcare products such as prefilled syringes and vials. This is expected to impact the growth of the parenteral packaging market on a positive note. Similarly, the development of new biotechnology products with specific requirements will create growth prospects.
Leading companies are constantly integrating automated systems to increase productivity, minimize contamination risks, and reduce costs. This will bode well for the parenteral packaging industry.
Top parenteral packaging companies are using new raw materials for their products to woo more and more customers. Sourcing and final packaging of raw materials between the manufacturers and the suppliers are creating an effective collaboration across the globe.
Polymers are gaining significant attention in manufacturing parenteral packaging. This is due to their advantages like break-free nature and high tensile strength compared to glass and plastic. The new packaging solutions made from these polymers are quite favorable for newly developed pharmaceutical drugs.
The packaging industry is shifting towards manufacturing multi-compartment packaging products to fit various products efficiently. This trend is positively impacting the parenteral packaging industry.
Manufacturers of parenteral products are focusing more on providing two drugs in a single administering dose, such as IV bags and prefilled syringes. The innovative packaging solutions of double and triple chambers are required to minimize major issues such as entry of pathogens, contamination, and sepsis.
The rising trend of self-medication in developed countries is expected to drive the sales of parenteral packaging. Subsequently, the increasing need for biologics and other novel drugs will likely boost the growth of the parenteral packaging industry.
| Particular | Value CAGR |
|---|---|
| H1 | 4.5% (2023 to 2033) |
| H2 | 3.9% (2023 to 2033) |
| H1 | 3.5% (2024 to 2034) |
| H2 | 4.0% (2024 to 2034) |
North America, spearheaded by the United States, is set to continue to lead the global market with a value share of around 25.2% in 2034. As per the latest analysis, the North America parenteral packaging market is poised to expand at 4.0% CAGR, totaling USD 5,070.9 million by 2034.
This is attributable to the expanding pharmaceutical industry, growing demand for injectable drug packaging, and the presence of leading parenteral packaging companies.
Asia Pacific’s parenteral packaging market is set to witness robust growth during the forecast period. This can be attributable to the rising incidence of chronic and infectious diseases, the growing need for pharmaceutical vial packaging, and the rise in vaccination programs.
| Country | Value (CAGR) |
|---|---|
| United States | 3.0% |
| Canada | 6.0% |
| Brazil | 6.4% |
| Germany | 3.6% |
| United Kingdom | 3.8% |
| China | 6.0% |
| India | 6.6% |
| Japan | 3.6% |
| GCC countries | 5.0% |
| South Africa | 6.7% |
As per the latest analysis, sales of parenteral packaging products in Canada are projected to rise at a CAGR of 6.0% during the forecast period. By 2034, Canada’s parenteral packaging market size is set to reach USD 1,882.1 million. This can be attributed to factors like
Canada is witnessing a strong demand for high-quality medical solutions. This is due to the growing prevalence of chronic diseases and rising health awareness. Driven by this, sales of parenteral packaging in the country will likely surge rapidly through 2034.
Another prominent factor expected to boost the growth of the parenteral packaging market in Canada is the rising healthcare spending. According to the Canadian Institute for Health Information, Canada’s total health spending reached around USD 344 billion in 2023. This is expected to create growth opportunities for parenteral packaging manufacturers.
India’s parenteral packaging market value is projected to increase from USD 1,165.4 million in 2024 to USD 2,203.7 million by 2034. Overall demand for parenteral packaging in India will likely rise at 6.6% CAGR during the forecast period, driven by factors like:
India’s pharmaceutical sector is ranked third in terms of pharma production volume, growing at a CAGR of 9.4% in the past nine years. According to the Indian Brand Equity Presentation (IBEF), the country’s pharmaceutical sector supplies over 50% of the global demand for several vaccines.
The total market size of India’s pharma industry is expected to reach USD 130 billion by 2030. The domestic pharmaceutical industry will likely reach USD 57 billion by FY25. This will continue to uplift parenteral packaging market demand across India.
The low cost of production and the increase in research and development expenditure are providing pharma companies with a huge business opportunity for the domestic market. As parenteral packaging offers an extended shelf life for pharmaceutical drugs, its demand is expected to rise rapidly through 2034.
The rising need for high-quality packaging for injectable drugs is anticipated to improve India’s parenteral packaging market share during the assessment period.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The below section shows the prefilled syringes segment dominating the parenteral drug packaging market. It is estimated to hold a value share of 39.6% in 2034.
Based on material, the plastic segment is expected to hold a prominent market share of 56.1% in 2034, while the glass category will likely expand at a high CAGR of 4.7% during the assessment period.
| Product | Expected Value CAGR |
|---|---|
| Vials | 6.0% |
| Prefilled Syringes | 5.3% |
The prefilled syringes segment dominates the parenteral packaging industry, which is expected to continue during the forecast period. It is poised to expand at 5.3% CAGR, holding a share of 39.6% in the parenteral drug packaging market at the end of 2034. This is attributable to factors like:
Demand for prefilled syringes has significantly increased since the COVID-19 outbreak. These products cater to the increasing need for safe and convenient medication delivery methods.
Prefilled syringes are particularly useful for self-administration because they are pre-loaded with a precise medication dosage. They minimize the risk of medication overdoses and underdoses that can happen with vials and ampoules.
The usage of prefilled syringes minimizes drug wastage as well as increases the lifespan of the drug. They are becoming an efficient, convenient, and reliable product for the healthcare industry. The growing popularity of prefilled syringes due to their multiple benefits will continue to boost the target segment as well as the market.
| Material | Value CAGR |
|---|---|
| Glass | 4.7% |
| Plastic | 4.6% |
The plastic segment is expected to hold a dominant market share of 56.1% in 2034. Over the forecast period, the target segment will likely expand at a CAGR of 4.6%, totaling USD 11,288.2 million by 2034.
Plastic remains the most preferred material for parenteral packaging. This is due to the growing popularity of plastic-based parenteral packaging like vials and ampoules. Leading parenteral packaging manufacturers are using plastic for making their products, owing to its attractive benefits like:
Plastic material is less fragile and less prone to breakage than alternate packaging solutions such as glass. As a result, it is widely used for producing parenteral packaging products.
Another factor expected to boost the target segment is the growing popularity of bioplastics. Amid the crackdown on plastic usage, several manufacturers of parenteral packaging are shifting their preference towards using bioplastics. They are becoming an ideal alternative to traditional plastics for parenteral packaging.
On the other hand, the glass segment is set to witness a higher CAGR of 4.7% during the assessment period. This can be attributable to several benefits of glass, including superior barrier properties and excellent chemical resistance.
Top manufacturers of parenteral packaging are developing innovative designs catering to specific products or applications. They are also focusing on offering sustainable solutions made from eco-friendly and recycled materials.
Several parenteral packaging companies are integrating novel technologies like automation to improve product quality and reduce labor costs. The target market is also witnessing strategies like mergers, acquisitions, facility expansions, collaborations, distribution agreements, and partnerships.
Recent Developments in the Parenteral Packaging Market-
| Attribute | Details |
|---|---|
| Estimated Market Value (2024) | USD 12,791.2 million |
| Projected Market Value (2034) | USD 20,115.6 million |
| Expected Growth Rate (2024 to 2034) | 4.6% CAGR |
| Historical Data | 2019 to 2023 |
| Forecast Period | 2024 to 2034 |
| Quantitative Sq. Mt. | Revenue in USD million, Volume in tons, and CAGR from 2024 to 2034 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product, Material, Packaging Format, Region |
| Key Regions Covered | North America; Latin America; Asia Pacific Ex. Japan; Western Europe; Eastern Europe; Middle East & Africa; Japan |
| Key Companies Profiled | Schott AG; UDG Healthcare Plc.; Gerresheimer AG.; Becton, Dickinson and Company; Catalent Inc. Stevanato Group S.p.A; Baxter International Inc.; Nipro Corporation; West Pharmaceutical Services, Inc.; Adelphi Healthcare Packaging; Ypsomed Holding AG; Terumo Corporation; SiO2 Materials Science.; SGD Pharma; PCI Pharma Services; Ardena Holding NV; Berkshire Sterile Manufacturing; Akorn, Inc.; Alcami Corporation, Inc.; Berry Global Inc. |
The parenteral packaging market value is estimated to total USD12,791.2 million in 2024.
Demand for parenteral packaging is projected to grow at 4.6% CAGR through 2034.
In 2034, the parenteral packaging market size is set to reach USD 20,115.6 million.
Rising prevalence of chronic diseases and growing need for effective drug delivery methods.
Becton, Dickinson and Company, West Pharmaceutical Services Inc., and Catalent Inc.
Containers and closures are used for sterile medications that are administered by injection or infusion.
Plastic like PVC and polyolefin are widely used in parenteral packaging.
| Estimated Size, 2025 | USD 112.3 billion |
|---|---|
| Projected Size, 2035 | USD 153.9 billion |
| Value-based CAGR (2025 to 2035) | 3.2% |
| Estimated Size, 2024 | USD 2.3 billion |
|---|---|
| Projected Size, 2034 | USD 3.7 billion |
| Value-based CAGR (2024 to 2034) | 5.2% |
| Market Size 2023 | USD 22,487 million |
|---|---|
| Market Size 2033 | USD 54,219.8 million |
| Market Value CAGR (2023 to 2033) | 9.2% |
| Market Size (2023) | USD 12137.2 million |
|---|---|
| Market Size (2033) | USD 24,099.7 million |
| Market CAGR (2023 to 2033) | 7.10% |
Explore Packaging Formats Insights
View Reports
Parenteral Packaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
